These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 4362422)

  • 1. [Hypersensitivity to synthetic ACTH (Synacthen) in patients with bronchial asthma].
    Obtulowicz K; Glowacka A
    Pol Tyg Lek; 1974 Mar; 29(12):473-4. PubMed ID: 4362422
    [No Abstract]   [Full Text] [Related]  

  • 2. [Synthetic ACTH therapy in allergic diseases].
    Hajós M
    Orv Hetil; 1970 May; 111(22):1268-72. PubMed ID: 4318341
    [No Abstract]   [Full Text] [Related]  

  • 3. [Corticotropic effectiveness and allergenicity of the synthetic ACTH tetracoacetid synacthen depot].
    Geyer G; Reimer EE
    Wien Klin Wochenschr; 1970 May; 82(18):324-32. PubMed ID: 4324930
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anaphylactic shock following the administration of ACTH of a patient with bronchial asthma].
    Oberemchenko IaV; Polikarpov BM; Klimov VA
    Vrach Delo; 1971; (2):53-5. PubMed ID: 4329183
    [No Abstract]   [Full Text] [Related]  

  • 5. [Synthetic depot-ACTH, plasmacortisol levels, and asthmatic syndrome (author's transl)].
    Illig H; Giesen HK
    Med Klin; 1975 Feb; 70(9):377-9. PubMed ID: 164616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A synthetic polypeptide--beta 1-24 corticotropin--in the depot form. II. Clinical efficacy of intermittent therapy in asthmatic patients.
    Benos SA; Koutsoukos A; Sotirakis I; Pavlatos FC
    Acta Allergol; 1969 Sep; 24(3):178-86. PubMed ID: 4314190
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experiences with synthetic ACTH (Synacthen)].
    Jordan D; Lee S; Meves C; Milbradt R
    Hautarzt; 1971 Apr; 22(4):159-64. PubMed ID: 4324253
    [No Abstract]   [Full Text] [Related]  

  • 8. [Synacthen-depot treatment during withdrawal of long-term corticotherapy in patients with asthma].
    Obtulowicz K; Glowacka A
    Pol Tyg Lek; 1974 Apr; 29(13):519-22. PubMed ID: 4363174
    [No Abstract]   [Full Text] [Related]  

  • 9. [Bronchial asthma. Pathogenetic assumptions - therapeutic guidelines - the significance of synthetic corticotrophin (ACTH) in its treatment (author's transl)].
    Brinkmann OH; Junge-Hülsing G
    Med Klin; 1975 Nov; 70(45):1821-6. PubMed ID: 172768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of sequence 1-39 human synthetic ACTH in therapy of asthmatic syndromes].
    Pozzi E; Scala C
    Clin Ter; 1980 May; 93(3):319-27. PubMed ID: 6256122
    [No Abstract]   [Full Text] [Related]  

  • 11. [Synthetic depot-ACTH in the treatment of obstructive bronchial diseases].
    Frank A
    Wien Med Wochenschr; 1971 Nov; 121(47):844-8. PubMed ID: 4331890
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anti-synthetic beta-1-24 corticotropin antibodies].
    Charpin J; Vague P; Aubert J; Vervloet D; Anfosso-Capra F; Di Campo C
    Biomedicine; 1974 Aug; 21(8):349-52. PubMed ID: 4374266
    [No Abstract]   [Full Text] [Related]  

  • 13. [Severe bronchial obstruction as a reaction to the administration of the tetracosactides depot-Cortrosyn and depot-Synacthen].
    Roldaan AC; de Jong C
    Ned Tijdschr Geneeskd; 1981 Feb; 125(8):321-3. PubMed ID: 6261167
    [No Abstract]   [Full Text] [Related]  

  • 14. [ACTH in the treatment of patients with bronchial asthma (author's transl)].
    Janacek M; Arslanagić H; Pardon R
    Plucne Bolesti Tuberk; 1978; 30(1-2):66-9. PubMed ID: 209488
    [No Abstract]   [Full Text] [Related]  

  • 15. [Case of ACTH-hypersensitivity].
    Nakamura S
    Arerugi; 1966 Apr; 15(4):239-44. PubMed ID: 4289632
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anaphylactic shock with fatal outcome after injection of synthetic corticotropin (Synacthen Depot) in a patient with severe asthma].
    Abjörn C; Leonhardt T
    Lakartidningen; 1970 Sep; 67(39):4364-6. PubMed ID: 4319253
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunologic responses to an adrenocorticotropic hormone preparation in bronchial asthma and rheumatoid arthritis.
    Muranaka M; Okumura H; Takeda K; Kikutani T; Koizumi K
    J Allergy; 1970 Sep; 46(3):138-49. PubMed ID: 4318935
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of chronic refractory skin diseases with synthetic ACTH, Cortrocin-depot].
    Hayakawa M
    Hifuka Kiyo; 1970 Feb; 65(1):51-61. PubMed ID: 4321317
    [No Abstract]   [Full Text] [Related]  

  • 19. [Action of a new synthetic ACTH drug in psoriatic arthropathy].
    Hundeiker M
    Z Hautkr; 1976 Aug; 51(16):663-8. PubMed ID: 184614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synacthen depot in the treatment of some dermatological diseases].
    Mazurkiewicz W; D abrowska H
    Przegl Dermatol; 1972; 59(3):377-82. PubMed ID: 4340580
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.